One hundred and two newly diagnosed children with malignancy followed up at the Pediatric Oncology Department of Ankara Oncology Hospital were investigated for hepatitis B, hepatitis C and human immunodeficiency virus markers.
The ages ranged between seven months and 17 years with a median of 10 years ; 62 were male.
Twenty-four patients had Hodgkin's disease, 11 had non-Hodgkin's lymphoma and 67 patients had other solid tumours.
Four patients had positive HBs-Ag, 15 developed immunity against hepatitis B and had anti-HBs antibodies.
One patient had a previous infection with positive anti-HBc.
Hepatitis C virus antibodies were positive in only one patient.
HIV serology was negative in all patients.
These results show the high prevalence of hepatitis B virus infection in paediatric oncology patients.
In countries where hepatitis B is endemic, strict screening of blood donors, usage of disposable equipment and vaccination of patients is recommended.
Although the incidence of hepatitis C and human immunodeficiency virus infections are rising, infection with hepatitis B is still by far the most common.
Mots-clés Pascal : Virus hépatite B, Hepadnaviridae, Virus, Virus hépatite C, Flaviviridae, Virus immunodéficience humaine, Lentivirinae, Retroviridae, Cancérologie, Pédiatrie, Malade, Prévalence, Séropositivité, Epidémiologie, Enfant, Homme, Turquie, Asie
Mots-clés Pascal anglais : Hepatitis B virus, Hepadnaviridae, Virus, Hepatitis C virus, Flaviviridae, Human immunodeficiency virus, Lentivirinae, Retroviridae, Cancerology, Pediatrics, Patient, Prevalence, Seropositivity, Epidemiology, Child, Human, Turkey, Asia
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0473266
Code Inist : 002B30A01A2. Création : 10/04/1997.